Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Oct-24 4:02 PM View:  | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Oct-24 | Planned Option Sale | 1,000 | $1,054.06 | $1,054,060.00 | (7%) 14.11K to 13.11K | |
| 03-Oct-24 4:02 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 01-Oct-24 | Option Exercise | 1,000 | $381.40 | $381,400.00 | 8% 13.11K to 14.11K | |
| 03-Oct-24 4:02 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Oct-24 | Private Sale (Planned) | 100 | $1,048.78 | $104,878.00 | (< 1%) 17.68K to 17.58K | |
| 05-Sep-24 4:01 PM View: | Sing George L Director | Regeneron Pharmaceuticals I... (REGN) | 04-Sep-24 | Gift | 1,200 | -- | -- | (4%) 29.62K to 28.42K | |
| 05-Sep-24 4:01 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 03-Sep-24 | Planned Option Sale | 1,000 | $1,178.73 | $1,178,730.00 | (7%) 14.11K to 13.11K | |
| 05-Sep-24 4:01 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 03-Sep-24 | Option Exercise | 1,000 | $381.40 | $381,400.00 | 8% 13.11K to 14.11K | |
| 05-Sep-24 4:01 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 03-Sep-24 | Private Sale (Planned) | 100 | $1,178.68 | $117,868.00 | (< 1%) 17.78K to 17.68K | |
| 29-Aug-24 4:27 PM View: | Fenimore Christopher R. SVP Finance & CFO | Regeneron Pharmaceuticals I... (REGN) | 28-Aug-24 | Private Sale | 5,680 | $1,205.33 | $6,846,260.00 | (23%) 24.45K to 18.77K | |
| 19-Aug-24 4:01 PM View: | Poon Christine A Director | Regeneron Pharmaceuticals I... (REGN) | 15-Aug-24 | Option Exercise | 10,838 | $413.33 | $4,479,670.00 | 499% 2.17K to 13.01K | |
| 19-Aug-24 4:02 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 15-Aug-24 | Option Exercise | 756 | $371.40 | $280,778.00 | 55% 1.38K to 2.14K | |
| 19-Aug-24 4:01 PM View: | Poon Christine A Director | Regeneron Pharmaceuticals I... (REGN) | 15-Aug-24 | Option Sale | 10,838 | $1,158.17 | $12,552,300.00 | (83%) 13.01K to 2.17K | |
| 19-Aug-24 4:02 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 15-Aug-24 | Planned Option Sale | 756 | $1,170.00 | $884,520.00 | (35%) 2.14K to 1.38K | |
| 15-Aug-24 4:01 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 14-Aug-24 | Planned Option Sale | 6,363 | $1,153.15 | $7,337,500.00 | (11%) 58.99K to 52.63K | |
| 15-Aug-24 4:01 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 13-Aug-24 | Payment of Exercise | 13,637 | $1,141.49 | $15,566,500.00 | (19%) 72.63K to 58.99K | |
| 14-Aug-24 4:01 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 13-Aug-24 | Gift | 500 | -- | -- | (< 1%) 60.55K to 60.05K | |
| 15-Aug-24 4:01 PM View: | Murphy Andrew J EVP Research | Regeneron Pharmaceuticals I... (REGN) | 13-Aug-24 | Option Exercise | 20,000 | $399.66 | $7,993,200.00 | 38% 52.63K to 72.63K | |
| 12-Aug-24 4:05 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 12-Aug-24 | Gift | 900 | -- | -- | (1%) 61.45K to 60.55K | |
| 12-Aug-24 4:05 PM View: | Stahl Neil EVP Research and Development | Regeneron Pharmaceuticals I... (REGN) | 08-Aug-24 | Private Sale | 5,197 | $1,084.54 | $5,636,350.00 | (8%) 66.65K to 61.45K | |
| 07-Aug-24 4:40 PM View: | Pitofsky Jason VP Controller | Regeneron Pharmaceuticals I... (REGN) | 07-Aug-24 | Option Sale | 487 | $1,070.00 | $521,090.00 | (10%) 4.7K to 4.21K | |
| 07-Aug-24 4:40 PM View: | Pitofsky Jason VP Controller | Regeneron Pharmaceuticals I... (REGN) | 07-Aug-24 | Option Exercise | 487 | $372.46 | $181,388.00 | 12% 4.21K to 4.7K | |
| 05-Aug-24 4:05 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 02-Aug-24 | Option Exercise | 756 | $371.40 | $280,778.00 | 55% 1.38K to 2.14K | |
| 05-Aug-24 4:05 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 02-Aug-24 | Planned Option Sale | 756 | $1,115.00 | $842,940.00 | (35%) 2.14K to 1.38K | |
| 05-Aug-24 4:01 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Aug-24 | Private Sale (Planned) | 1 | $1,100.03 | $1,100.03 | (< 1%) 17.78K to 17.78K | |
| 05-Aug-24 4:01 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 01-Aug-24 | Private Sale (Planned) | 99 | $1,085.53 | $107,467.00 | (< 1%) 17.88K to 17.78K | |
| 12-Jul-24 4:00 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 11-Jul-24 | Private Sale (Planned) | 1,866 | $1,088.95 | $2,031,980.00 | (5%) 40.17K to 38.31K | |
| 25-Jun-24 4:39 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 24-Jun-24 | Payment of Exercise | 11,084 | $1,060.13 | $11,750,500.00 | (22%) 51.26K to 40.17K | |
| 25-Jun-24 4:41 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 24-Jun-24 | Option Exercise | 756 | $371.40 | $280,778.00 | 55% 1.38K to 2.14K | |
| 25-Jun-24 4:41 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 24-Jun-24 | Planned Option Sale | 756 | $1,062.00 | $802,872.00 | (35%) 2.14K to 1.38K | |
| 25-Jun-24 4:39 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 24-Jun-24 | Option Exercise | 14,450 | $555.67 | $8,029,430.00 | 39% 36.81K to 51.26K | |
| 17-Jun-24 4:01 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 14-Jun-24 | Planned Private Option Sale | 1,535 | $1,040.00 | $1,596,400.00 | (11%) 14.08K to 12.54K | |
| 17-Jun-24 4:01 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 14-Jun-24 | Option Exercise | 1,535 | $625.60 | $960,296.00 | 12% 12.54K to 14.08K | (< 1%) |
| 13-Jun-24 4:01 PM View: | Schleifer Leonard S Bd. Co-Chair, President & CEO Director | Regeneron Pharmaceuticals I... (REGN) | 12-Jun-24 | Conversion | 1,000 | -- | -- | < 1% 685.5K to 686.5K | |
| 13-Jun-24 4:01 PM View: | Schleifer Leonard S Bd. Co-Chair, President & CEO Director | Regeneron Pharmaceuticals I... (REGN) | 12-Jun-24 | Sale (Planned) | 16,149 | $1,015.94 | $16,406,400.00 | (2%) 686.5K to 670.35K | |
| 13-Jun-24 4:01 PM View: | Schleifer Leonard S Bd. Co-Chair, President & CEO Director | Regeneron Pharmaceuticals I... (REGN) | 11-Jun-24 | Private Sale (Planned) | 9,064 | $1,015.43 | $9,203,820.00 | (1%) 694.56K to 685.5K | |
| 12-Jun-24 4:10 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 10-Jun-24 | Gift | 1,608 | -- | -- | (4%) 38.42K to 36.81K | |
| 12-Jun-24 4:10 PM View: | Yancopoulos George Bd. Co-Chair, President & CSO Director | Regeneron Pharmaceuticals I... (REGN) | 10-Jun-24 | Gift | 37,900 | -- | -- | 3% 1.15M to 1.19M | |
| 12-Jun-24 4:10 PM View: | Yancopoulos George Bd. Co-Chair, President & CSO Director | Regeneron Pharmaceuticals I... (REGN) | 10-Jun-24 | Gift | 75,799 | -- | -- | (6%) 1.19M to 1.11M | |
| 10-Jun-24 4:03 PM View: | Schleifer Leonard S Bd. Co-Chair, President & CEO Director | Regeneron Pharmaceuticals I... (REGN) | 06-Jun-24 | Private Sale (Planned) | 787 | $1,015.02 | $798,821.00 | (< 1%) 695.35K to 694.56K | |
| 07-Jun-24 4:06 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 05-Jun-24 | Option Exercise | 827 | $380.95 | $315,046.00 | 60% 1.38K to 2.21K | |
| 07-Jun-24 4:06 PM View: | Bassler Bonnie L Director | Regeneron Pharmaceuticals I... (REGN) | 05-Jun-24 | Planned Option Sale | 827 | $1,011.00 | $836,097.00 | (37%) 2.21K to 1.38K | |
| 05-Jun-24 4:07 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 03-Jun-24 | Planned Option Sale | 1,138 | $980.16 | $1,115,420.00 | (8%) 14.24K to 13.11K | |
| 05-Jun-24 4:06 PM View: | Ryan Arthur F Director | Regeneron Pharmaceuticals I... (REGN) | 03-Jun-24 | Private Sale (Planned) | 100 | $994.50 | $99,449.70 | (< 1%) 18.08K to 17.98K | |
| 05-Jun-24 4:07 PM View: | McCourt Marion EVP Commercial | Regeneron Pharmaceuticals I... (REGN) | 03-Jun-24 | Option Exercise | 1,138 | $372.46 | $423,859.00 | 9% 13.11K to 14.24K | |
| 29-May-24 4:01 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 28-May-24 | Planned Private Option Sale | 1,172 | $974.86 | $1,142,540.00 | (9%) 13.72K to 12.54K | |
| 29-May-24 4:01 PM View: | Brown Michael S Director | Regeneron Pharmaceuticals I... (REGN) | 28-May-24 | Option Exercise | 1,172 | $625.60 | $733,203.00 | 9% 12.54K to 13.72K | (< 1%) |
| 22-May-24 4:02 PM View: | Larosa Joseph J EVP General Counsel and Secret | Regeneron Pharmaceuticals I... (REGN) | 21-May-24 | Private Sale (Planned) | 1,865 | $994.90 | $1,855,490.00 | (5%) 40.28K to 38.42K | |
| 17-May-24 5:57 PM View: | Schleifer Leonard S Bd. Co-Chair, President & CEO Director | Regeneron Pharmaceuticals I... (REGN) | 17-May-24 | Private Sale (Planned) | 22,830 | $979.22 | $22,355,700.00 | (3%) 718.18K to 695.35K | |
| 17-May-24 4:06 PM View: | Yancopoulos George Bd. Co-Chair, President & CSO Director | Regeneron Pharmaceuticals I... (REGN) | 16-May-24 | Private Sale (Planned) | 50,000 | $972.73 | $48,636,500.00 | (4%) 1.2M to 1.15M | |
| 17-May-24 4:04 PM View: | Yancopoulos George Bd. Co-Chair, President & CSO Director | Regeneron Pharmaceuticals I... (REGN) | 15-May-24 | Private Sale (Planned) | 50,000 | $975.88 | $48,793,700.00 | (4%) 1.25M to 1.2M | |
| 15-May-24 6:10 PM View: | Schleifer Leonard S Bd. Co-Chair, President & CEO Director | Regeneron Pharmaceuticals I... (REGN) | 15-May-24 | Planned Option Sale | 10,941 | $980.34 | $10,725,900.00 | (2%) 729.12K to 718.18K |
